Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Anaplastic Malignant Neoplasm · CancerIndex

Cancers
Neoplasm
Neoplasm by Special Category
Malignant Neoplasm
Anaplastic Malignant Neoplasm

Cancer Family

Anaplastic Malignant Neoplasm

CI-CAN-00000065Explore in graph →

546 active trials4 approved drugs57 evidence items

NCIt: C36025

Overview
Statistics
Survival
Genomics1
Variants & evidence57
Drugs21
Trials2019
Research
Rankings
Sources & provenance

Data completeness5 / 7 dimensions

Epidemiology (no data yet)
Survival (no data yet)
Trials (data present)
Literature (data present)
Genomics (data present)
Evidence (data present)
Therapies (data present)

Computed from entity_counters.completeness · refreshed after each connector run

Definition

What this entity is

A malignant neoplasm characterized by the presence of poorly differentiated, often large neoplastic cells with bizarre morphologic characteristics, associated with high mitotic activity and necrotic changes.

Definition text as published by ncit-evsProvenance

Source: NCI Thesaurus (NCIt)
Dataset: NCI Thesaurus
Version: 26.08e
Retrieved: Sep 8, 2026
Layer: raw (as published)
Evidence: expert curation
License: CC BY 4.0
Run: ING-NCITEVS-20260908-000001

Open at source Curated

Data updated 22 days agoSource updated 26.08e

Taxonomy

Position in the hierarchies

Several hierarchies coexist; edges are listed per hierarchy type with their source.

Parents

ncit

Malignant NeoplasmCancer Family

Children (16)

ncit

Anaplastic Astrocytoma10 sub
Anaplastic Brain Stem Glioma1 sub
Anaplastic Ependymoma2 sub
Anaplastic Ganglioglioma
Anaplastic Kidney Wilms Tumor
Anaplastic Large Cell Lymphoma19 sub
Anaplastic (Malignant) Meningioma3 sub
Anaplastic Oligoastrocytoma2 sub
Anaplastic Oligodendroglioma5 sub

Anatomy

Anatomical sites

Data not yet available

No anatomical site linked yet.

Record

Identity

CancerIndex ID: CI-CAN-00000065
Entity type: Cancer Family
Malignant: Yes
Solid / hematologic: Solid tumor
Pediatric relevant: Not flagged
Rare cancer: Unknown (no incidence data yet)
Hierarchy depth: 3
Classification version: 26.08e
Semantic types: Neoplastic Process
Status: Active
Record updated: 2026-09-08

Coverage

Data completeness

Trials (all / active)

Anaplastic Plasmacytoma

Anaplastic Pleomorphic Xanthoastrocytoma

Anaplastic Sarcoma of the Kidney1 sub

Astrocytoma, IDH-Mutant, Grade 4

Glioblastoma11 sub

Sarcomatoid Carcinoma14 sub

Testicular Seminoma with High Mitotic Index

149 descendants in total; counters on this page aggregate over all of them.

2,019 / 546

Publications (all / 5y)

191 / 21

Evidence items

57

Genes / variants

100 / 37

Drugs (any / approved)

21 / 4

Genomic cohorts

1

Epidemiology / survival obs.

0 / 0

Data updated 18 hours agoSource updated unknowncounters aggregate over descendants

Names

Synonyms (1)

Anaplastic Cancersynonym · NCIt

CancerIndex is a research and information platform. It does not diagnose and does not recommend treatment.

Key figures

At a glance

Each figure carries its unit, period and source; ranks link to "Why this rank?".

No registry-level ancestor: burden figures are published for the mutually exclusive top-level site groups only, and this entity does not descend from one. Global figures (IARC / GLOBOCAN) stay under license review and SEER awaits credentials.

Active trials546countcurrent registry status · entity + descendantsclinicaltrialsComputedrank #71 of 1,654 (World · both sexes · all ages · latest · all malignant entities)
Recruiting trials292countstatus RECRUITING · entity + descendantsclinicaltrialsComputedrank #71 of 1,277 (World · both sexes · all ages · latest · all malignant entities)
Curated evidence items57countaccepted CIViC items · entity + descendantscivicComputedrank #78 of 492 (World · both sexes · all ages · latest · all malignant entities)
Publications, last 12 months0countPubMed records · stored query · 12-month windowpubmedComputednot in a current ranking snapshot
Genomic cohorts1countopen GDC projects · entity + descendantsgdcComputedrank #228 of 296 (World · both sexes · all ages · latest · all malignant entities)

Data updated 18 hours agoSource updated unknownregistry figures: none · counters aggregate over descendants